Immune‑blot band patterns in inactive liver cysts from cystic echinococcosis
Official title: Comparison of Immunoblotting Bands Pattern in Patients With Treated Versus Untreated Inactive Echinococcal Cysts of the Liver
Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07333612 · Data updated 2026-11-12
This will test whether immunoblot band patterns differ between treated and untreated adults with inactive echinococcal cysts in the liver.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia Academic / other |
| Locations | 1 site (Pavia, PV) |
| Status | Recruiting |
| Started | September 23, 2025 |
| Main results expected | May 1, 2026 |
| Study ends | September 1, 2026 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT07333612 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with hepatic cystic echinococcosis who have undergone at least two clinical evaluations and have inactive liver cysts are the intended participants.
✕Probably not a fit
People with echinococcal cysts outside the liver, children under 18, or those with fewer than two clinical evaluations are not eligible and unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect blood samples and clinical data from adults with hepatic cystic echinococcosis who have had at least two clinical evaluations, comparing those who received treatment to those who remain untreated. Immunoblotting will be performed on serum to characterize antibody band patterns associated with inactive liver cysts. This is an observational, single‑center protocol conducted at Fondazione IRCCS Policlinico San Matteo di Pavia with no interventions assigned by the study. The aim is to see if distinct immunoblot signatures correlate with treated versus untreated inactive hepatic cysts.
Why it matters
Potential benefit: If successful, this could provide a noninvasive laboratory marker to help monitor treatment response and distinguish treated from untreated inactive liver cysts.
How similar studies have gone: Immunoblotting has been used to detect antibodies in echinococcosis, but using specific band patterns to separate treated versus untreated inactive hepatic cysts is relatively novel with limited prior evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Only Hepatic echinococcal cysts * Age \> 18 years * At leat 2 clinical evaluation Exclusion Criteria: * different location of echinococcal cysts * Age \< 18 years --less then 2 clinical evalutation
Where it's running
-
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pv, Italy Recruiting
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.